Cargando…

Association of abnormal carbon dioxide levels with poor neurological outcomes in aneurysmal subarachnoid hemorrhage: a retrospective observational study

BACKGROUND: In patients with aneurysmal subarachnoid hemorrhage (SAH), an association between hypocapnia and poor clinical outcomes has been reported. However, the optimal arterial carbon dioxide tension (PaCO(2)) remains unknown. The present retrospective study aimed to examine the association of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoyama, Shota, Hifumi, Toru, Okazaki, Tomoya, Noma, Takahisa, Kawakita, Kenya, Tamiya, Takashi, Minamino, Tetsuo, Kuroda, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296027/
https://www.ncbi.nlm.nih.gov/pubmed/30574334
http://dx.doi.org/10.1186/s40560-018-0353-1
_version_ 1783380962787196928
author Yokoyama, Shota
Hifumi, Toru
Okazaki, Tomoya
Noma, Takahisa
Kawakita, Kenya
Tamiya, Takashi
Minamino, Tetsuo
Kuroda, Yasuhiro
author_facet Yokoyama, Shota
Hifumi, Toru
Okazaki, Tomoya
Noma, Takahisa
Kawakita, Kenya
Tamiya, Takashi
Minamino, Tetsuo
Kuroda, Yasuhiro
author_sort Yokoyama, Shota
collection PubMed
description BACKGROUND: In patients with aneurysmal subarachnoid hemorrhage (SAH), an association between hypocapnia and poor clinical outcomes has been reported. However, the optimal arterial carbon dioxide tension (PaCO(2)) remains unknown. The present retrospective study aimed to examine the association of abnormal PaCO(2) levels with neurological outcomes and investigate the optimal target PaCO(2) level in patients with SAH. METHODS: We retrospectively selected consecutive adult patients hospitalized in the intensive care unit (ICU) for SAH between January 2009 and April 2017. Univariate and multivariate analyses were performed to identify the independent predictors of unfavorable neurological outcomes (i.e., modified Rankin scale score of 3–6 on hospital discharge). RESULTS: Among 158 patients with SAH, 73 had unfavorable neurological outcomes. During the first 2 weeks in the ICU, the median number of PaCO(2) measurements per patient was 43. The factors significantly associated with unfavorable neurological outcomes were age, Hunt and Kosnik grade, maximum lactate levels during the first 24 h, and maximum (odds ratio [OR], 1.12; 95% confidence interval [CI], 1.03–1.21; p < 0.01) and minimum PaCO(2) levels (OR, 0.81; 95% CI, 0.72–0.92; p < 0.01). Receiver operating characteristic curve analysis revealed that the cutoff range of PaCO(2) was 30.2–48.3 mmHg. Unfavorable neurological outcomes were noted in 78.8% of patients with PaCO(2) levels outside this range and in 22.8% of patients with PaCO(2) levels within this range. CONCLUSIONS: Both the maximum and minimum PaCO(2) levels during ICU management in patients with SAH were significantly associated with unfavorable neurological outcomes. Further prospective studies are required to validate our findings and explore their clinical implications. Our findings may provide a scientific rationale for these future prospective studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40560-018-0353-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6296027
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62960272018-12-20 Association of abnormal carbon dioxide levels with poor neurological outcomes in aneurysmal subarachnoid hemorrhage: a retrospective observational study Yokoyama, Shota Hifumi, Toru Okazaki, Tomoya Noma, Takahisa Kawakita, Kenya Tamiya, Takashi Minamino, Tetsuo Kuroda, Yasuhiro J Intensive Care Research BACKGROUND: In patients with aneurysmal subarachnoid hemorrhage (SAH), an association between hypocapnia and poor clinical outcomes has been reported. However, the optimal arterial carbon dioxide tension (PaCO(2)) remains unknown. The present retrospective study aimed to examine the association of abnormal PaCO(2) levels with neurological outcomes and investigate the optimal target PaCO(2) level in patients with SAH. METHODS: We retrospectively selected consecutive adult patients hospitalized in the intensive care unit (ICU) for SAH between January 2009 and April 2017. Univariate and multivariate analyses were performed to identify the independent predictors of unfavorable neurological outcomes (i.e., modified Rankin scale score of 3–6 on hospital discharge). RESULTS: Among 158 patients with SAH, 73 had unfavorable neurological outcomes. During the first 2 weeks in the ICU, the median number of PaCO(2) measurements per patient was 43. The factors significantly associated with unfavorable neurological outcomes were age, Hunt and Kosnik grade, maximum lactate levels during the first 24 h, and maximum (odds ratio [OR], 1.12; 95% confidence interval [CI], 1.03–1.21; p < 0.01) and minimum PaCO(2) levels (OR, 0.81; 95% CI, 0.72–0.92; p < 0.01). Receiver operating characteristic curve analysis revealed that the cutoff range of PaCO(2) was 30.2–48.3 mmHg. Unfavorable neurological outcomes were noted in 78.8% of patients with PaCO(2) levels outside this range and in 22.8% of patients with PaCO(2) levels within this range. CONCLUSIONS: Both the maximum and minimum PaCO(2) levels during ICU management in patients with SAH were significantly associated with unfavorable neurological outcomes. Further prospective studies are required to validate our findings and explore their clinical implications. Our findings may provide a scientific rationale for these future prospective studies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40560-018-0353-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-12-17 /pmc/articles/PMC6296027/ /pubmed/30574334 http://dx.doi.org/10.1186/s40560-018-0353-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Yokoyama, Shota
Hifumi, Toru
Okazaki, Tomoya
Noma, Takahisa
Kawakita, Kenya
Tamiya, Takashi
Minamino, Tetsuo
Kuroda, Yasuhiro
Association of abnormal carbon dioxide levels with poor neurological outcomes in aneurysmal subarachnoid hemorrhage: a retrospective observational study
title Association of abnormal carbon dioxide levels with poor neurological outcomes in aneurysmal subarachnoid hemorrhage: a retrospective observational study
title_full Association of abnormal carbon dioxide levels with poor neurological outcomes in aneurysmal subarachnoid hemorrhage: a retrospective observational study
title_fullStr Association of abnormal carbon dioxide levels with poor neurological outcomes in aneurysmal subarachnoid hemorrhage: a retrospective observational study
title_full_unstemmed Association of abnormal carbon dioxide levels with poor neurological outcomes in aneurysmal subarachnoid hemorrhage: a retrospective observational study
title_short Association of abnormal carbon dioxide levels with poor neurological outcomes in aneurysmal subarachnoid hemorrhage: a retrospective observational study
title_sort association of abnormal carbon dioxide levels with poor neurological outcomes in aneurysmal subarachnoid hemorrhage: a retrospective observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296027/
https://www.ncbi.nlm.nih.gov/pubmed/30574334
http://dx.doi.org/10.1186/s40560-018-0353-1
work_keys_str_mv AT yokoyamashota associationofabnormalcarbondioxidelevelswithpoorneurologicaloutcomesinaneurysmalsubarachnoidhemorrhagearetrospectiveobservationalstudy
AT hifumitoru associationofabnormalcarbondioxidelevelswithpoorneurologicaloutcomesinaneurysmalsubarachnoidhemorrhagearetrospectiveobservationalstudy
AT okazakitomoya associationofabnormalcarbondioxidelevelswithpoorneurologicaloutcomesinaneurysmalsubarachnoidhemorrhagearetrospectiveobservationalstudy
AT nomatakahisa associationofabnormalcarbondioxidelevelswithpoorneurologicaloutcomesinaneurysmalsubarachnoidhemorrhagearetrospectiveobservationalstudy
AT kawakitakenya associationofabnormalcarbondioxidelevelswithpoorneurologicaloutcomesinaneurysmalsubarachnoidhemorrhagearetrospectiveobservationalstudy
AT tamiyatakashi associationofabnormalcarbondioxidelevelswithpoorneurologicaloutcomesinaneurysmalsubarachnoidhemorrhagearetrospectiveobservationalstudy
AT minaminotetsuo associationofabnormalcarbondioxidelevelswithpoorneurologicaloutcomesinaneurysmalsubarachnoidhemorrhagearetrospectiveobservationalstudy
AT kurodayasuhiro associationofabnormalcarbondioxidelevelswithpoorneurologicaloutcomesinaneurysmalsubarachnoidhemorrhagearetrospectiveobservationalstudy